Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy-Reference-Cited by-同舟云学术

Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy

Published:2020-01-13 Issue:1 Volume:14 Page:255-271
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Xie Ying¹,Hang Yu¹,Wang Yazhe¹,Sleightholm Richard¹,Prajapati Dipakkumar R.²,Bader Johannes¹³,Yu Ao¹,Tang Weimin¹,Jaramillo Lee¹⁴,Li Jing¹,Singh Rakesh K.²,Oupický David¹^ORCID

Affiliation:

1. Center for Drug Delivery and Nanomedicine, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

2. Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States

3. Department of Pharmacy, Pharmaceutical Technology and Biopharmacy, Ludwig-Maximilians-Universität München, 81337 Munich, Germany

4. Bohemica Pharmaceuticals, LLC, La Vista, Nebraska 68128, United States

Funder

National Center for Advancing Translational Sciences

University of Nebraska Medical Center

China Scholarship Council

Nebraska Department of Economic Development

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science